Rosuvastatin Completed Phase 1 Trials for Dyslipidemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03175835Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT02364258Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients